본문 바로가기
KERD
논문KCI 등재

Establishing Epidemiological Cutoff Values for Helicobacter pylori Strains in Korea: A Model-Based Analysis of Antibiotic Resistance Patterns

Establishing Epidemiological Cutoff Values for Helicobacter pylori Strains in Korea: A Model-Based Analysis of Antibiotic Resistance Patterns

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Background/Aims: The absence of standardized clinical minimum inhibitory concentration (MIC) breakpoints for Helicobacter pylori infection has resulted in inconsistent resistance definitions, even within the same research group in Korea. Therefore, establishing epidemiological cutoff values (ECOFFs) is essential for standardization. Methods: The MIC distributions for antibiotics commonly used against H. pylori infection in South Korea were analyzed from 2015 to 2023. A total of 5,925 primary H. pylori isolates were collected from five data sources, and MIC values were determined using the serial 2-fold agar dilution method. The ECOFFinder program was used to establish ECOFFs for six antibiotics. Results: The tentative ECOFFs for amoxicillin and clarithromycin were 0.125 μg/mL. The ECOFFs for levofloxacin, metronidazole, and tetracycline were 0.5, 8.0, and 0.25 μg/mL, respectively. The ECOFF for rifabutin could not be determined due to insufficient data. On the basis of these ECOFFs, the resistance rate was 17.9% for amoxicillin, 31.9% for clarithromycin, 40.9% for levofloxacin, 24.7% for metronidazole, and 11.5% for tetracycline. Conclusions: This comprehensive analysis defined regional antibiotic resistance patterns and established Korea-specific ECOFFs, providing a foundation for determining clinical breakpoints and optimizing H. pylori eradication strategies.

Abstract

Background/Aims: The absence of standardized clinical minimum inhibitory concentration (MIC) breakpoints for Helicobacter pylori infection has resulted in inconsistent resistance definitions, even within the same research group in Korea. Therefore, establishing epidemiological cutoff values (ECOFFs) is essential for standardization. Methods: The MIC distributions for antibiotics commonly used against H. pylori infection in South Korea were analyzed from 2015 to 2023. A total of 5,925 primary H. pylori isolates were collected from five data sources, and MIC values were determined using the serial 2-fold agar dilution method. The ECOFFinder program was used to establish ECOFFs for six antibiotics. Results: The tentative ECOFFs for amoxicillin and clarithromycin were 0.125 μg/mL. The ECOFFs for levofloxacin, metronidazole, and tetracycline were 0.5, 8.0, and 0.25 μg/mL, respectively. The ECOFF for rifabutin could not be determined due to insufficient data. On the basis of these ECOFFs, the resistance rate was 17.9% for amoxicillin, 31.9% for clarithromycin, 40.9% for levofloxacin, 24.7% for metronidazole, and 11.5% for tetracycline. Conclusions: This comprehensive analysis defined regional antibiotic resistance patterns and established Korea-specific ECOFFs, providing a foundation for determining clinical breakpoints and optimizing H. pylori eradication strategies.

관련 논문AI추천

Antibiotic Resistance in Helicobacter pylori Strains and its Effect on H. pylori Eradication Rates in a Single Center in Korea박민, 김사현, 김종배, 김희정, 문병수, 안병락, 이규상, 이용찬, 임현철대한진단검사의학회 · Annals of Laboratory Medicine2013 · 제33권 제6호A Nationwide Trend Analysis of Helicobacter pylori Treatment between 2010 and 2021 According to Revised Guidelines in KoreaBang Chang Seok, Choi Yoon Jin, Jo Junwoo, Lee Moon Won, Nam Su Youn, Seo Seung In, Shin Woon Geon거트앤리버 소화기연관학회협의회 · Gut and Liver2026 · 제20권 제1호Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020김지현, 이용찬, 임현철, Cheol Min Shin, Hye-Kyung Jung, Hyo-Joon Yang, Il Ju Choi, Jae Gyu Kim, Jae Myung Park, Miyoung Choi, Seon-Young Park, Seung Joo Kang, Sung Eun Kim, Su Youn Nam, Woon Geon Shin대한내과학회 · The Korean Journal of Internal Medicine2021 · 제36권 제4호Korean Registry on the Current Management of Helicobacter pylori (K-Hp-Reg): Interim Analysis of Adherence to the Revised Evidence-Based Guidelines for First-Line TreatmentAhn Ji Yong, Bang Chang Seok, Choe Younghee, Cho Jin Woong, Cho Joon Hyun, Hong Su Jin, Jee Sam Ryong, Jeon Seong Woo, Joo Moon Kyung, Kim Beom Jin, Kim Dae-Hyun, Kim Gwang Ha, Kim Jae Gyu, Kim Joon Sung, Kim Shin Hee, Kim Sun-Moon, Kwon Yong Hwan, Lee Jong Yeul, Lee Ju Yup, Lee Ok-Jae, Lim Hyun, Oh Tae Hoon, Park Jae Myung, Park Jae Yong, Park Moo In, Park Seon-Young, Song Hyun Joo, Yang Hyo-Joon거트앤리버 소화기연관학회협의회 · Gut and Liver2025 · 제19권 제3호Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from VietnamDang Thuy Ha, Duong Minh Thang, Ho Dang Quy Dung, Nguyen Quang Duat, Pham Hong Khanh, Tran Manh Hai, Tran Thanh Binh, Tran Thi Huyen Trang, Vu Van Khien, Yoshio Yamaoka거트앤리버 소화기연관학회협의회 · Gut and Liver2019 · 제13권 제5호Substitutions in Penicillin-Binding Protein 1 in Amoxicillin-Resistant Helicobacter pylori Strains Isolated from Korean Patients김범진, 김재규거트앤리버 소화기연관학회협의회 · Gut and Liver2013 · 제7권 제6호

이 간행물의 다른 논문 (16건)